The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples